Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Risperidone Augmentation in Patients With Schizophrenia Partially Responsive to Clozapine

NCT00289861 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT00289861
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00289861 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Risperidone Augmentation in Patients With Schizophrenia Partially Responsive to Clozapine
Lead sponsor
Massachusetts General Hospital
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2003
Completion date
March 31, 2007
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schizophrenia